Droplet reduces genomic analysis time using NVIDIA Parabricks, enabling rapid turnaround of test results CAMBRIDGE, Mass., March 3, 2026 /PRNewswire/ -- Droplet Biosciences, a diagnostics company ...

In exploring barriers in rare disease research and drug development, experts highlight a lack of robust models, limited trial ...

Published as an arXiv preprint, the paper details how unsupervised and self-supervised AI models are matching or surpassing ...

After 50 days of forced stillness, one Angeleno finds clarity through movement, alignment and service in a city built on reinvention.

Oxford Nanopore Technologies plc ( ONTTF) Q4 2025 Earnings Call March 2, 2026 5:45 AM EST Good morning, everyone, and thank you for joining us today. Before we move into the 2025 results presentation, ...

Mitochondria possess their own mRNA translation system, mediated by specialized mitoribosomes. Dysregulation of mitochondrial translation disrupts metabolic homeostasis and is linked to various ...

New Program Designed as Platform-based Approach for Direct Correction of Mutations Causing PKU; Investigational New Drug (IND) Filing for ...

A 91-year-old man with a history of bladder carcinoma and left total knee arthroplasty was evaluated because of left knee pain. A culture of synovial fluid showed no growth. A diagnosis was made.

Australia’s human tissue acts are set for their first overhaul in 50 years, in a move that is hoped to remove hurdles to donation and medical and research innovation.

The key lies in disciplined breakdown and structured programming. When the right professionals focus on the right elements, ...

An AI system called DeepRare outperformed experienced physicians in diagnosing rare diseases, according to a new study ...